Medicare Part D — delivering prescription drugs to seniors — has been a success since President Bush introduced it. And the Obama administration plans to threaten that achievement.

Among many matters being discussed in the debate over the debt limit are proposals to reform health insurance policies used to supplement Medicare, such as so-called Medigap plans. Such reforms reportedly could save $53 billion over ten years.

Medicare must continue to implement reforms to align its coverage and payment policies with the value delivered to beneficiaries.

Murray Aitken, vice president of IMS Health, the world's largest source of drug-price and sales data, and MIT professor Ernst Berndt will explain why their research shows that average drug prices for seniors have declined, not increased, by more than 20 percent.

Medicare is facing a fiscal calamity: how can the growth of Medicare spending be limited while ensuring that beneficiaries continue to have access to affordable health care?

The Obama administration has been trying to stem the tide of skepticism toward its health care law with a new mailer sent directly to the nation's seniors, but a four-page pamphlet will not convince them that ObamaCare is a good deal.